国际泌尿系统杂志
國際泌尿繫統雜誌
국제비뇨계통잡지
INTERNATIONAL JOURNAL OF UROLOGY AND NEPHROLOGY
2009年
6期
724-726
,共3页
林天旗%郑周达%庄少鹉%许振强%林海利%庄志明%张朝贤
林天旂%鄭週達%莊少鵡%許振彊%林海利%莊誌明%張朝賢
림천기%정주체%장소무%허진강%림해리%장지명%장조현
肾结石%栓寒%治疗性%出血%输尿管镜检
腎結石%栓寒%治療性%齣血%輸尿管鏡檢
신결석%전한%치료성%출혈%수뇨관경검
Kidney Calculi%Embolization%Therapentic%Hemorrhage%Ureteroscopy
目的 探讨超选择性肾动脉栓塞治疗经皮肾镜取石(Percutaneous nephrostolithotomy.PC-NL)术后肾脏大出血的应用价值.方法 采用超选择性肾动脉栓塞术治疗5例PCNL术后肾脏大出血患者,所有病例在栓塞前都经肾动脉造影证实诊断,超选择插管至肾段动脉或分支出血处,以明胶海绵颗粒条和金属钢圈为材料进行栓塞.结果 所有患者术后临床症状如肉眼血尿很快缓解,止血成功率达100%.术后平均随访11个月,无再发肾脏出血,血压及肾功能均正常.结论 超选择性肾动脉栓塞术微创、疗效好、并发症少,能最大限度地保留肾功能,是冶疗PCNL术后大出血最安全有效的方法.
目的 探討超選擇性腎動脈栓塞治療經皮腎鏡取石(Percutaneous nephrostolithotomy.PC-NL)術後腎髒大齣血的應用價值.方法 採用超選擇性腎動脈栓塞術治療5例PCNL術後腎髒大齣血患者,所有病例在栓塞前都經腎動脈造影證實診斷,超選擇插管至腎段動脈或分支齣血處,以明膠海綿顆粒條和金屬鋼圈為材料進行栓塞.結果 所有患者術後臨床癥狀如肉眼血尿很快緩解,止血成功率達100%.術後平均隨訪11箇月,無再髮腎髒齣血,血壓及腎功能均正常.結論 超選擇性腎動脈栓塞術微創、療效好、併髮癥少,能最大限度地保留腎功能,是冶療PCNL術後大齣血最安全有效的方法.
목적 탐토초선택성신동맥전새치료경피신경취석(Percutaneous nephrostolithotomy.PC-NL)술후신장대출혈적응용개치.방법 채용초선택성신동맥전새술치료5례PCNL술후신장대출혈환자,소유병례재전새전도경신동맥조영증실진단,초선택삽관지신단동맥혹분지출혈처,이명효해면과립조화금속강권위재료진행전새.결과 소유환자술후림상증상여육안혈뇨흔쾌완해,지혈성공솔체100%.술후평균수방11개월,무재발신장출혈,혈압급신공능균정상.결론 초선택성신동맥전새술미창、료효호、병발증소,능최대한도지보류신공능,시야료PCNL술후대출혈최안전유효적방법.
Objectives To discuss the application of transcatbeter supersclective arterial embolization on treatment of renal hemorrhage after PCNL. Methods 5 patients with renal hemorrhage after PCNL were treated by superselective renal artery embolization . All patients underwent angiographic examinations and the definite diagnosis before the embolization. The catheters were inserted ,into the kidney artery or its branches selectively through the for-mal artery. Materials used in the embolizatian were gelfoam and steel coils. Results Clinical symptoms such as macroscopic hemsturia subsided quickly after operation. With an average follow-up of 11 months, no hemorrhage reoccurred in renal, the blood pressure and the renal function were normal in all patients. Conclusions Superse-lective renal arterial embolization has advantages of less invasive, less complications, and good haemostatic efficacy, with maximal preservation of renal function for treatment of renal hemorrhage after PCNL.